1. Home
  2. SSBI vs EQ Comparison

SSBI vs EQ Comparison

Compare SSBI & EQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Summit State Bank

SSBI

Summit State Bank

SELL

Current Price

$11.39

Market Cap

77.1M

Sector

Finance

ML Signal

SELL

Logo Equillium Inc.

EQ

Equillium Inc.

N/A

Current Price

$1.52

Market Cap

89.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSBI
EQ
Founded
1982
2017
Country
United States
United States
Employees
103
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
77.1M
89.4M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SSBI
EQ
Price
$11.39
$1.52
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $8.56
AVG Volume (30 Days)
2.8K
★ 344.2K
Earning Date
10-27-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $41,095,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.23
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.50
$1.16
52 Week High
$14.00
$6.20

Technical Indicators

Market Signals
Indicator
SSBI
EQ
Relative Strength Index (RSI) 34.42 53.88
Support Level $11.36 $1.30
Resistance Level $13.59 $2.53
Average True Range (ATR) 0.27 0.13
MACD -0.05 0.04
Stochastic Oscillator 7.38 79.55

Price Performance

Historical Comparison
SSBI
EQ

About SSBI Summit State Bank

Summit State Bank provides various banking products and services to individuals and businesses in Sonoma County, California. It offers personal and business checking, money market, sweep, savings, and demand accounts; time certificates of deposit; and specialized deposit accounts, such as professional, small business packaged, tiered, and retirement plan accounts. The company also provides loans, including commercial loans and leases; lines of credit; commercial real estate, small business administration, residential mortgage, and construction loans; home equity lines of credit; and term and equipment loans, as well as loans to agriculture-related businesses.

About EQ Equillium Inc.

Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydrocarbon receptor, or AhR, modulator, into and through clinical development. The Company operates through a single operating and reportable segment focused on the business of developing novel therapies to treat severe autoimmune and inflammatory disorders, with the mission to develop life-changing therapeutics for patients. The Company manages all business activities on a consolidated basis.

Share on Social Networks: